Mednet Logo
HomeQuestion

How do you monitor response for stage III NSCLC patients receiving consolidation immunotherapy?

3 Answers
Mednet Member
Mednet Member
Medical Oncology · Cedars-Sinai Medical Center

Generally, the first imaging post chemoradiation (CRT) would have been performed about 6-8 weeks following completion, and this has changed as we start durvalumab within 42 days following CRT. I perform a baseline CT chest prior to starting durvalumab. I proceed to monitor with CT chest about every ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Pacific Cancer Medcl Center Inc

Ct every 3 months

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Tufts University School of Medicine

CT every 3 months for first year and increase interval per disease burden and stability.

Register or Sign In to see full answer

How do you monitor response for stage III NSCLC patients receiving consolidation immunotherapy? | Mednet